Is HBPCF or QYLD a better dividend investment in 2026?

HBPCF currently yields 115.61% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: HBPCF offers higher current income.

What is the dividend yield difference between HBPCF and QYLD?

HBPCF has a forward dividend yield of 115.61% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 103.69 percentage points.

Home › Compare › HBPCF vs QYLD

HBPCF vs QYLD: Dividend Comparison 2026

HBPCF yields 115.61% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HBPCF wins by $7.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HBPCF

● Live price

115.61%

Share price

$1.73

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.23M

Annual income

$2,676,132.53

Full HBPCF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — HBPCF vs QYLD

📍 HBPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HBPCF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HBPCF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HBPCF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBPCF

Annual income on $10K today (after 15% tax)

$9,826.59/yr

After 10yr DRIP, annual income (after tax)

$2,274,712.65/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, HBPCF beats the other by $2,269,902.24/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBPCF + QYLD for your $10,000?

HBPCF: 50%QYLD: 50%

100% QYLD50/50100% HBPCF

Portfolio after 10yr

$3.63M

Annual income

$1,340,895.92/yr

Blended yield

36.96%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBPCF buys

QYLD buys

No recent congressional trades found for HBPCF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHBPCFQYLD

Forward yield	115.61% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7.23M	$25.4K ✓
Annual income after 10y	$2,676,132.53 ✓	$5,659.31
Total dividends collected	$6.55M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: HBPCF vs QYLD ($10,000, DRIP)

Year	HBPCF Portfolio	HBPCF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$22,261	$11,560.69	$10,352	$1,192.36	+$11.9K → HBPCF
2	$47,870	$24,051.31	$10,830	$1,347.57	+$37.0K → HBPCF
3	$99,558	$48,337.27	$11,460	$1,539.07	+$88.1K → HBPCF
4	$200,481	$93,953.00	$12,275	$1,777.84	+$188.2K → HBPCF
5	$391,330	$176,815.76	$13,323	$2,078.95	+$378.0K → HBPCF
6	$741,281	$322,558.19	$14,667	$2,463.34	+$726.6K → HBPCF
7	$1,364,208	$571,036.96	$16,396	$2,960.57	+$1.35M → HBPCF
8	$2,441,853	$982,150.40	$18,631	$3,612.97	+$2.42M → HBPCF
9	$4,255,766	$1,642,983.32	$21,548	$4,482.15	+$4.23M → HBPCF
10	$7,229,802	$2,676,132.53	$25,398	$5,659.31	+$7.20M → HBPCF

HBPCF vs QYLD: Complete Analysis 2026

HBPCF — Stock

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Full HBPCF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this HBPCF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBPCF vs SCHD HBPCF vs JEPI HBPCF vs O HBPCF vs KO HBPCF vs MAIN HBPCF vs XYLD HBPCF vs JEPQ HBPCF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.